Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 17, Number 3—March 2011

Research

Mycobacterium tuberculosis Cluster with Developing Drug Resistance, New York, New York, USA, 2003–2009

Bianca R. PerriComments to Author , Douglas Proops, Patrick K. Moonan, Sonal S. Munsiff, Barry N. Kreiswirth, Natalia Kurepina, Christopher Goranson, and Shama D. Ahuja
Author affiliations: Author affiliations: New York City Department of Health and Mental Hygiene, New York, New York, USA (B.R. Perri, D. Proops, S.S. Munsiff, C. Goranson, S.D. Ahuja); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (B.R. Perri, P.K. Moonan, S.S. Munsiff); Public Health Research Institute Tuberculosis Center, Newark, New Jersey, USA (B.N. Kreiswirth, N. Kurepina)

Main Article

Figure 1

Cluster of 54 cases of tuberculosis (TB), by year of diagnosis, New York, New York, USA, 2003–2009. The 54 cases include 1 in a patient in the city of New York who was given a diagnosis of drug-susceptible Mycobacterium tuberculosis infection in 2007 that was counted by New York State.

Figure 1. Cluster of 54 cases of tuberculosis (TB), by year of diagnosis, New York, New York, USA, 2003–2009. The 54 cases include 1 in a patient in the city of New York who was given a diagnosis of drug-susceptible Mycobacterium tuberculosis infection in 2007 that was counted by New York State.

Main Article

TOP